569 related articles for article (PubMed ID: 29157616)
21. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Tsuneyama A; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neurol Sci; 2020 Jun; 413():116771. PubMed ID: 32172013
[TBL] [Abstract][Full Text] [Related]
22. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
23. POEMS Syndrome.
Dispenzieri A
Hematology Am Soc Hematol Educ Program; 2005; ():360-7. PubMed ID: 16304404
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome.
Kulkarni GB; Mahadevan A; Taly AB; Yasha TC; Seshagiri KS; Nalini A; Satishchandra P; Veerendrakumar M; Shankar SK
J Clin Neurosci; 2011 Mar; 18(3):356-60. PubMed ID: 21256753
[TBL] [Abstract][Full Text] [Related]
25. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
Paranavitane S; Gooneratne L; Chang T
J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
[TBL] [Abstract][Full Text] [Related]
26. POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2021 Jul; 96(7):872-888. PubMed ID: 34000085
[TBL] [Abstract][Full Text] [Related]
27. How I treat POEMS syndrome.
Dispenzieri A
Blood; 2012 Jun; 119(24):5650-8. PubMed ID: 22547581
[TBL] [Abstract][Full Text] [Related]
28. The POEMS syndrome: report of six cases.
Pareyson D; Marazzi R; Confalonieri P; Mancardi GL; Schenone A; Sghirlanzoni A
Ital J Neurol Sci; 1994 Oct; 15(7):353-8. PubMed ID: 7698893
[TBL] [Abstract][Full Text] [Related]
29. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
31. Adenopathy and extensive skin patch overlying a plasmacytoma with unusual histologic findings in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome and Castleman disease.
Dagrosa AT; Cowdrey MCE; LeBlanc RE; Lansigan F; Kaur P; Carter JB
J Cutan Pathol; 2019 Oct; 46(10):784-789. PubMed ID: 31119772
[TBL] [Abstract][Full Text] [Related]
32. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
[TBL] [Abstract][Full Text] [Related]
33. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
Twigg J; Methley A; Lavin T; Dickinson G; Teager A
Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
[TBL] [Abstract][Full Text] [Related]
34. Castleman disease variant of POEMS syndrome complicated with multiple cerebral infarction: a rare case report and review of literature.
Yu H; Yao F; Li Y; Li J; Cui QC
Int J Clin Exp Pathol; 2015; 8(10):13578-83. PubMed ID: 26722578
[TBL] [Abstract][Full Text] [Related]
35. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
36. [POEMS syndrome (or Crow-Fukase syndrome)].
Lagueny A; Bouillot S; Vital C; Ferrer X; Larrieu JM; Vital A
Rev Neurol (Paris); 2004 Mar; 160(3):285-95. PubMed ID: 15037841
[TBL] [Abstract][Full Text] [Related]
37. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
38. POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin lesions) syndrome: a South America's report.
Leite AC; Nascimento OJ; Lima MA; Andrada-Serpa MJ
Arq Neuropsiquiatr; 2007 Jun; 65(2B):516-20. PubMed ID: 17665027
[TBL] [Abstract][Full Text] [Related]
39. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
40. [POEMS Syndrome with central and peripheric nervous system demyelination].
Masjuan Vallejo J; Herrero Valverde A; Mera Campillo J; López Jiménez J
Neurologia; 2003 Oct; 18(8):465-9. PubMed ID: 14615950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
